Clostridium difficile infection in low- and middle-human development index countries: a systematic review

Trop Med Int Health. 2017 Oct;22(10):1223-1232. doi: 10.1111/tmi.12937. Epub 2017 Aug 31.

Abstract

Objective: To describe the impact and epidemiology of Clostridium difficile infection (CDI) in low- and middle-human development index (LMHDI) countries.

Method: Prospectively registered, systematic literature review of existing literature in the PubMed, Ovid and Web of Science databases describing the epidemiology and management of C. difficile in LMHDI countries. Risk factors were compared between studies when available.

Results: Of the 218 abstracts identified after applying search criteria, 25 studies were reviewed in detail. The weighted pooled infection rate among symptomatic non-immunosuppressed inpatients was 15.8% (95% CI 12.1-19.5%) and was 10.1% (95% CI 3.0-17.2%) among symptomatic outpatients. Subgroup analysis of immunosuppressed patient populations revealed pooled infection rates similar to non-immunosuppressed patient populations. Risk factor analysis was infrequently performed.

Conclusions: While the percentages of patients with CDI in LMHDI countries among the reviewed studies are lower than expected, there remains a paucity of epidemiologic data evaluating burden of C. difficile infection in these settings.

Keywords: C. difficile infection; analyse systématique; infección por C. difficile infection; infection à C. difficile; low- and middle-income countries; pays à revenu faible et intermédiaire; países con ingresos bajos y medios; revisión sistemática; systematic review.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Clostridioides difficile / drug effects
  • Clostridioides difficile / immunology
  • Clostridium Infections / complications*
  • Clostridium Infections / drug therapy
  • Clostridium Infections / epidemiology
  • Clostridium Infections / immunology
  • Colitis, Ulcerative / epidemiology
  • Colitis, Ulcerative / immunology*
  • Comorbidity
  • Developing Countries / statistics & numerical data*
  • Diarrhea / etiology
  • HIV Infections / epidemiology
  • HIV Infections / immunology*
  • Humans
  • Immunocompromised Host / drug effects
  • Immunocompromised Host / immunology*

Substances

  • Anti-Bacterial Agents